Why methotrexate suboptimal dosing is a potential source of bias in biologic drugs clinical trials. Issue 8 (24th May 2016)

Record Type:: Journal Article
Title:: Why methotrexate suboptimal dosing is a potential source of bias in biologic drugs clinical trials. Issue 8 (24th May 2016)
Main Title:: Why methotrexate suboptimal dosing is a potential source of bias in biologic drugs clinical trials
Authors:: Durán, Josefina
Felson, David T
Abstract:
Is Part Of:: Annals of the rheumatic diseases. Volume 75:Issue 8(2016)
Journal:: Annals of the rheumatic diseases
Issue:: Volume 75:Issue 8(2016)
Issue Display:: Volume 75, Issue 8 (2016)
Year:: 2016
Volume:: 75
Issue:: 8
Issue Sort Value:: 2016-0075-0008-0000
Page Start:: e53
Page End:: e53
Publication Date:: 2016-05-24
Subjects:: Rheumatoid Arthritis -- Methotrexate -- Treatment -- DMARDs (biologic)
Rheumatism -- Periodicals
616.723005
Journal URLs:: http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗
DOI:: 10.1136/annrheumdis-2016-209791 ↗
Languages:: English
ISSNs:: 0003-4967
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 18043.xml